News & Opinionn

 

Targeted Therapies Could Reduce Side Effects

 

By Alanna McCatty

April 9, 2018

Targeted Therapies Could Reduce Side Effects

Treatments that are applied to non-target areas within the body can lead to unnecessary side effects and cause debilitating symptoms. In some instances, this can prompt patients to stop their course of treatment early. In an effort to combat this and limit side effects, researchers are in the process of designing and developing light-activated small molecules that can be switched on and off in the body.

The treatments would be designed to target and penetrate a specific area, according to an article published in Chemical & Engineering News. A good example of this would be where doctors turn on chemotherapy agents to kill tumors and turn on antibiotics to wipe out bacteria within the body.

Although photoswitchable (also known as photodynamic) therapies aren’t new, they are still in the process of being developed and have some drawbacks. For instance, certain therapies are switched on with UV light, but wavelengths don’t penetrate very far through the skin and can cause mutations.

Additionally, the treatment may face some pushback when it comes to obtaining regulatory approvals because it is very complex. Despite some of the anticipated obstacles, chemists are moving forward with their research in hope that more selective therapies could be used to treat patients in need.

Average: 0
Alanna McCatty
Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.

 

Last updated: April 9, 2018